Residency Competency Assessments and Early-Career Primary Care Physicians’ Antibiotic Prescribing - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Evaluating Residency Competency and Its Impact on Antibiotic Prescribing Practices Among Early-Career Primary Care Physicians

  • By

  • Jesse Burk-Rafel

  • Hannah Park

  • MacIntosh Cornwell

  • Eric S. Holmboe

  • Kenji Yamazaki

  • Sally A. Santen

  • Yoon Soo Park

  • John S. Andrews

  • Sean O. Hogan

  • Judee Richardson

  • September 17, 2026

Share

  • 1

    Physicians exhibit significant variation in outpatient antibiotic prescribing, particularly affecting older adults who are vulnerable to complications.

  • 2

    Residency training may influence long-term antibiotic prescribing patterns, as it is a formative phase for developing practice behaviors.

  • 3

    The study linked ACGME Milestone competency ratings of PCPs to their early-career antibiotic prescribing patterns using Medicare claims.

  • 4

    Competency ratings cover six core domains and are assessed on a 5-point scale, with a score of 4.0 indicating readiness for unsupervised practice.

  • 5

    The research aims to identify individual and program-level factors associated with antibiotic prescribing variation among early-career PCPs.

Original Source(s)

Residency Competency Assessments and Early-Career Primary Care Physicians’ Antibiotic Prescribing

  • by Jesse Burk-Rafel, Hannah Park, MacIntosh Cornwell, Eric S. Holmboe, Kenji Yamazaki, Sally A. Santen, Yoon Soo Park, John S. Andrews, Sean O. Hogan, Judee Richardson

  • September 17, 2026

Related Content

Microsporidial keratoconjunctivitis may mimic allergy

Molecular testing identified Encephalitozoon hellem in a 9-year-old orthokeratology lens wearer after conventional treatment failed.

Half of pediatric mental health visits hit smaller EDs

Pediatric suicide-related visits showed a similar distribution, while patient and diagnostic characteristics differed across emergency settings.

FDA revises monitoring for SCLC therapy

Initial monitoring decreases from 22 to 24 hours to 6 to 8 hours from the start of the first 2 infusions.